Table 3.
Toxicity Grade2 | I | II | III | IV |
---|---|---|---|---|
| ||||
Short Term (n=45) | ||||
Adjuvant RT (n=17) | 9 (52.9%) | 7 (41.2%) | - | 1 (5.9%) |
Standard dose RT (n=16) | 6 (37.5%) | 6 (37.5%) | 4 (56.3%) | - |
Escalated dose RT (n=12) | 3 (25%) | 6 (50%) | 3 (25%) | - |
| ||||
Long Term (n=44)3 | ||||
Adjuvant RT (n=17) | 4 (23.5%) | 7 (41.2%) | 2 (23.5%) | 1 (5.9%) |
Standard dose RT (n=15) | 6 (37.5%) | 9 (60%) | - | - |
Escalated dose RT (n=12) | 2 (16.7%) | 5 (41.7%) | 3 (25%) | 1 (8.3%) |
Highest graded short and long term toxicities observed for each patient within each RT dosing group, across all toxicity categories.
Common Toxicity Criteria, Version 2.0, including the RTOG/EORTC Late Radiation Morbidity Scoring Scheme.
One standard dose RT patient taken off study < 3months after completion of RT due to distant failure.